Amarin Corp Plc (AMRN)

[Whalatane]

Mog While most of us here believe R-IT will show benefit , no one knows how much benefit .

So if R-IT on final read out shows only 15% benefit ( thus trial was still a success ) would Vascepa still become a huge seller or would Health Providers such as Kaiser still refuse to cover for the CV benefit and simply instruct CAD patients to use DS alternatives like Omegia Via EPA ( 88% EPA ) and eat more Salmon.

As I've written before .
Most agree that Zetia provides at least 6% risk reduction ...but Kaiser has withdrawn coverage as they believe its not worth it for them and stress more , diet , exercise , no smoking etc.

By the way , since you mentioned no insider buys .
Has there been any open market insider sells ?

Raf ...if U are reading this .
If U owe Mog a $100 , hope you send it .
Kiwi